Patent · US Active

Inhibitors of KIF18A and uses thereof

US12391709B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 14, 2025
Grant dateAug 19, 2025
Priority date
Expiry dateJan 14, 2045

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are compounds of the Formula (IIIA): or pharmaceutically acceptable salts thereof, which are useful for the inhibition of KIF18A and in the treatment of a variety of KIF18A mediated conditions or diseases, such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.